← Evidence map

ArticleDrug delivery and translational research2026

First-in-line subcutaneous injectable for reversible, non-hormonal male contraception.

Sarah Anne Howard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40425996